{"nct_id":"NCT04123366","title":"Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-03","start_date":"2019-11-18","start_date_type":"ACTUAL","primary_completion_date":"2026-07-23","primary_completion_date_type":"ESTIMATED","completion_date":"2026-07-23","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}